Corteva (CTVA) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
19 Mar, 2026Executive summary
Achieved strong 2025 performance with expanded earnings, margin growth, and over $1.5 billion returned to shareholders via dividends and share repurchases, while investing in R&D and disruptive technologies for long-term value creation.
Innovation in seed and crop protection drove margin growth, with Enlist E3 soybeans leading U.S. soybean technology and double-digit volume growth in biologicals.
Engaged with shareholders representing 48% of outstanding stock to discuss business strategy, governance, sustainability, and compensation.
Board recommends a slate of 12 highly qualified directors, with two retirements and two new nominees to support the proposed separation.
Voting matters and shareholder proposals
Shareholders will vote on: election of 12 directors, advisory approval of executive compensation, advisory vote on frequency of say-on-pay, ratification of PwC as independent auditor, and other business.
Board recommends voting FOR all director nominees, FOR executive compensation, FOR 1 YEAR frequency on say-on-pay, and FOR auditor ratification.
Proxy materials are available online, and voting can be done by internet, phone, or mail.
Board of directors and corporate governance
Board consists of 12 members, 92% independent, with 25% women and 17% ethnically/racially diverse; average tenure is 5 years.
Board committees: Audit, Governance and Compliance, People and Compensation, Sustainability and Innovation—all comprised of independent directors.
Annual board, committee, and individual director evaluations; regular refreshment and diversity focus.
Stockholders can nominate directors via proxy access; no super-majority voting requirements.
Latest events from Corteva
- Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.CTVA
Proxy filing19 Mar 2026 - Strong 2025 results and resilient nitrogen markets drive growth amid global and policy shifts.CTVA
Bank of America 2026 Global Agriculture and Materials Conference25 Feb 2026 - 2025 saw record margins, cash flow, and Bayer deal; 2026 set for further growth and separation.CTVA
Q4 20254 Feb 2026 - Seed strength and margin gains offset Crop Protection headwinds; 2024 outlook trimmed.CTVA
Q2 20242 Feb 2026 - 2024 guidance reaffirmed as cost savings, innovation, and strong seed performance drive long-term growth.CTVA
Wells Fargo 2024 Industrials Conference1 Feb 2026 - Seed growth, cost control, and innovation drive outlook despite Argentina and weather headwinds.CTVA
BMO Ag-Apalooza Conference20 Jan 2026 - 2024 guidance narrowed as Q3 sales fell, but 2025 outlook targets strong EBITDA growth.CTVA
Q3 202415 Jan 2026 - Record 2024 margins and cash flow; 2025 targets 10% EBITDA growth and $1B buybacks.CTVA
Q4 20248 Jan 2026 - Q1 2025 operating EBITDA up 15% to $1.19B with margin gains; $1B buyback planned.CTVA
Q1 20258 Jan 2026